期刊文献+

低流量型阴茎异常勃起的诊治分析 被引量:1

Diagnosis and treatment of low-flow priapism
原文传递
导出
摘要 目的探讨低流量型阴茎异常勃起的临床特点和治疗方法,提高急诊处理水平。方法低流量型阴茎异常勃起患者12例,年龄19~47岁,平均28岁。病程6~24h9例,24。72h2例,1例持续168h。阴茎海绵体内注射血管活性药物致异常勃起6例,白血病3例,口服药物所致1例,不明原因者2例。结合文献分析其治疗方法和预后。结果12例均为低流量型阴茎异常勃起。11例分别采用冰敷、阿拉明注射、阴茎海绵体抽吸和肝素化生理盐水冲洗及原发病治疗,阴茎勃起消退,1例行阴茎海绵体阴茎头分流术治愈。11例患者获得随访,时间6—24个月,4例出现不同程度ED。结论早期行阴茎海绵体抽吸冲洗是低流量型阴茎异常勃起的有效治疗方法,而白血病引起的阴茎异常勃起,阴茎海绵体抽吸冲洗可缓解症状,但易复发,积极治疗原发病多可使异常勃起自行缓解,分流手术多作为第二选择。 Objective To investigate the diagnosis and treatment of low-flow priapism. Methods The clinical data of 12 cases of low-flow priapism were analyzed retrospectively. The age ranged from 19 to 47years (mean 28) and the time of persistent erection lasted for 6~168h (9 cases less than 6~24 h, 2 during 24~72 h and 1 for 168h). Of them, 6 patients resulted from intracavernosal injecting vaso-active agents, 3 patients from chronic myeloid leukemia, 1 patient from intaked medicine, and the other 2 unknown causes. Results Among these 12 cases of low-flow priapism, they achieved detumescence by intracavernosal injecting aramine, intracavernosal aspiration and perfusing of heparinized saline at corporal cavernosa, and chemotherapy plus leukapheresis for chronic myeloid leukemia, respectively. One of them received glandular cavernosal shunting. After 6-24months following-up, 4 of 11 cases had erectile dysfunction. Conclusion Early treatment of intracavernosal aspiration and perfusing of heparinized saline at corporal cavernosa was an effective theraputical option for low-flow priapism. Chemotherapy plus leukapheresis was recommended as a first choice treatment for priapism caused by chronic myeloid leukemia. Caverno-spongiosum shunt might be also required but controvertible.
出处 《中国男科学杂志》 CAS CSCD 2011年第4期39-41,44,共4页 Chinese Journal of Andrology
关键词 阴茎异常勃起 诊断 治疗 priapism/diagnosis, therapy
  • 相关文献

参考文献10

二级参考文献76

  • 1陈戈明,赵伟平,朱选文,高文君,蔡松良,梁忠炎,王康儿,沈煜.阴茎异常勃起的诊断和治疗(附10例报告)[J].中华泌尿外科杂志,2004,25(11):765-767. 被引量:8
  • 2曹林升,周辉良.阴茎异常勃起的发病机制及其治疗[J].中国男科学杂志,2005,19(2):66-69. 被引量:9
  • 3Montague DK, Jarow J, Broderick GA, et al. American Urological Association Guideline on the management of priapism. J Urol 2003;170(4):1318-1324.
  • 4KulmAla RV, Lehtonen TA, Tammela TL. Priapism, its incidence and seasonAl distrubution in Finland. Scand J Urol Nephrol 1995; 29(1): 93-96.
  • 5Eland IA, Van der Lei J, Stricker BH, et al. Incidence of priapism in the generAl population. Urology 2001; 57 (5): 970-972.
  • 6Earle CM, Stuckey BG, Ching, et al. The incidence and management of priapism in Western Australia: a 16 year audit. Int J lmpot Res 2003; 15(4): 272-276.
  • 7Emond AM, Holman R Hayes R J, et al. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980; 140(11): 1434-1437.
  • 8Shamloul R, Ghanem HM, SAlem A, et al. The value of penile duplex in the prediction of intracavemous drug-inducedpriapism, lnt J Impot Res 2004; 16(1): 78-79.
  • 9Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986; 135(1): 142-147.
  • 10Berger R, Billups K, Brock G, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. lnt J Impot Res 2001; 13(1): S39-S43.

共引文献68

同被引文献14

  • 1Eland IA,van der Lei J,Strieker BH,et al.Incidence of pria-pism in the general population.Urology,2001,57(5):970-972.
  • 2Lue TF.Physiology of penile erection and pathophysiology of erectiledysfunction and priapism.In:Walsh PC,Retik AB,VaughanED Jr,Wein AJ,Kavoussi AR,et al,editors.Campbells Urolo-gy.Philadelphia:WB Saunders,2002.1610-1696.
  • 3Montague DK,Jarow J,Broderick GA,et al,American Urologi-cal Association guidelines on the management of priapism.Amer-ican Urological Association.J Urol,2003,170(4 Pt 1):1318-1324.
  • 4Lue TF.A refined approach to priapism.In:Erectile dysfunctionand Peyronie^ disease.90th Annual Meeting,Las Vegas,1995.
  • 5Melman A,Serels S.Priapism.Int J Impot Res,2000,12(Suppl 4):S133-139.
  • 6Costa WS,Felix B,Cavalcanti AG,et al.Structural analysis ofthe corpora cavernosa in patients with ischaemic priapism.BJUInt,2010,105(6):838-841.
  • 7Spycher MA,Hauri D.The ultrastructure of the erectile tissue inpriapism.J Urol,1986,135⑴:142-147.
  • 8Brant WO,Garcia MM,Bella AJ,et al.T-shaped shunt and in-tracavemous tunneling for prolonged ischemic priapism.J Urol,2009,181(4):1699-1705.
  • 9Lian W,Lu J,Cui W,et al,Al-Ghorab shunt plus intraca-ver-nous tunneling for prolonged ischemic priapism.J Androl,2010,31(5):466471.
  • 10Priapism NA.Pathophysiology and non-surgicai management.In:Porst H,Buvat J,editors.Standard practice in sexual medi-cine.Boston,MA; Blackwell Publishing,2006.174-179.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部